 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Eosinophil-derived neurotoxin (edn) - sulphate complex
|
|
Structure:
|
 |
Eosinophil-derived neurotoxin. Chain: a. Synonym: rnase-2, rnase-us, edn. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Tissue: blood. Cell: eosinophil. Organelle: granule. Cellular_location: secretory granules. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.6Å
|
R-factor:
|
0.177
|
R-free:
|
0.219
|
|
|
Authors:
|
 |
D.D.Leonidas,E.Boix,R.Prill,M.Suzuki,R.Turton,K.Minson, G.J.Swaminathan,R.J.Youle,K.R.Acharya
|
Key ref:
|
 |
D.D.Leonidas
et al.
(2001).
Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors.
J Biol Chem,
276,
15009-15017.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
02-Jan-01
|
Release date:
|
31-May-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P10153
(RNAS2_HUMAN) -
Non-secretory ribonuclease
|
|
|
|
Seq: Struc:
|
 |
 |
 |
161 a.a.
135 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.27.5
- Pancreatic ribonuclease.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotides ending in C-P or U-P with 2',3'-cyclic phosphate intermediates.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
chemotaxis
|
3 terms
|
 |
|
Biochemical function
|
nucleic acid binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:15009-15017
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN). High resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors.
|
|
D.D.Leonidas,
E.Boix,
R.Prill,
M.Suzuki,
R.Turton,
K.Minson,
G.J.Swaminathan,
R.J.Youle,
K.R.Acharya.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Eosinophil-derived neurotoxin (EDN), a basic ribonuclease found in the large
specific granules of eosinophils, belongs to the pancreatic RNase A family.
Although its physiological function is still unclear, it has been shown that EDN
is a neurotoxin capable of inducing the Gordon phenomenon in rabbits. EDN is
also a potent helminthotoxin and can mediate antiviral activity of eosinophils
against isolated virions of the respiratory syncytial virus. EDN is a
catalytically efficient RNase sharing similar substrate specificity with
pancreatic RNase A with its ribonucleolytic activity being absolutely essential
for its neurotoxic, helminthotoxic, and antiviral activities. The crystal
structure of recombinant human EDN in the unliganded form has been determined
previously (Mosimann, S. C., Newton, D. L., Youle, R. J., and James, M. N. G.
(1996) J. Mol. Biol. 260, 540-552). We have now determined high resolution (1.8
A) crystal structures for EDN in complex with adenosine-3',5'-diphosphate
(3',5'-ADP), adenosine-2',5'-di-phosphate (2',5'-ADP), adenosine-5'-diphosphate
(5'-ADP) as well as for a native structure in the presence of sulfate refined at
1.6 A. The inhibition constant of these mononucleotides for EDN has been
determined. The structures present the first detailed picture of differences
between EDN and RNase A in substrate recognition at the ribonucleolytic active
site. They also provide a starting point for the design of tight-binding
inhibitors, which may be used to restrain the RNase activity of EDN.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. A, C, and E, diagrams of the 1.8-Å sigmaA
2|F[o]| |F[c]|
electron density map of 3',5'-ADP, 2',5'-ADP, and 5'-ADP,
respectively. Electron density maps were calculated using the
standard protocol as implemented in X-PLOR 3.851 (60) from the
EDN model before incorporating the coordinates of each
inhibitor, are contoured at the 1.0 level, and
the refined structure of the inhibitor is shown. B, D, and F,
diagrams showing the interactions of 3',5'-ADP, 2',5'-ADP, and
5'-ADP with EDN, respectively. EDN residues are drawn as
ball-and-stick models, water molecules appear as gray spheres,
and the nucleotide molecules are shown in dark gray. Hydrogen
bonds are indicated by dashed lines.
|
 |
Figure 4.
Fig. 4. A and C, diagrams of the 1.8-Å sigmaA
2|F[o]| |F[c]|
electron density map calculated using the standard protocol as
implemented in X-PLOR 3.851 (58) from the EDN model before
incorporating the coordinates of sulfates A and B, respectively.
The map is contoured at the 1.0 level. The
EDN residues are shown in light gray. B and D, diagrams showing
the interactions of sulfate ions A and B with EDN, respectively.
EDN residues are drawn as ball-and-stick models, water molecules
appear as dark gray spheres, and the sulfate molecules are shown
in black. Hydrogen bonds are indicated by dashed lines. Diagrams
were drawn with BOBSCRIPT (61).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
15009-15017)
copyright 2001.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Torrent,
M.V.Nogués,
and
E.Boix
(2011).
Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
|
| |
J Mol Recognit, 24,
90.
|
 |
|
|
|
|
 |
D.E.Holloway,
G.B.Chavali,
D.D.Leonidas,
M.D.Baker,
and
K.R.Acharya
(2009).
Influence of naturally-occurring 5'-pyrophosphate-linked substituents on the binding of adenylic inhibitors to ribonuclease a: An X-ray crystallographic study.
|
| |
Biopolymers, 91,
995.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Sikriwal,
D.Seth,
and
J.K.Batra
(2009).
Role of catalytic and non-catalytic subsite residues in ribonuclease activity of human eosinophil-derived neurotoxin.
|
| |
Biol Chem, 390,
225-234.
|
 |
|
|
|
|
 |
M.Ulrich,
A.Petre,
N.Youhnovski,
F.Prömm,
M.Schirle,
M.Schumm,
R.S.Pero,
A.Doyle,
J.Checkel,
H.Kita,
N.Thiyagarajan,
K.R.Acharya,
P.Schmid-Grendelmeier,
H.U.Simon,
H.Schwarz,
M.Tsutsui,
H.Shimokawa,
G.Bellon,
J.J.Lee,
M.Przybylski,
and
G.Döring
(2008).
Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase.
|
| |
J Biol Chem, 283,
28629-28640.
|
 |
|
|
|
|
 |
D.Sikriwal,
D.Seth,
P.Dey,
and
J.K.Batra
(2007).
Human eosinophil-derived neurotoxin: involvement of a putative non-catalytic phosphate-binding subsite in its catalysis.
|
| |
Mol Cell Biochem, 303,
175-181.
|
 |
|
|
|
|
 |
E.Boix,
and
M.V.Nogués
(2007).
Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.
|
| |
Mol Biosyst, 3,
317-335.
|
 |
|
|
|
|
 |
D.D.Leonidas,
G.B.Chavali,
N.G.Oikonomakos,
E.D.Chrysina,
M.N.Kosmopoulou,
M.Vlassi,
C.Frankling,
and
K.R.Acharya
(2003).
High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
|
| |
Protein Sci, 12,
2559-2574.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.G.Mohan,
E.Boix,
H.R.Evans,
Z.Nikolovski,
M.V.Nogués,
C.M.Cuchillo,
and
K.R.Acharya
(2002).
The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site.
|
| |
Biochemistry, 41,
12100-12106.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.J.Swaminathan,
D.E.Holloway,
K.Veluraja,
and
K.R.Acharya
(2002).
Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin.
|
| |
Biochemistry, 41,
3341-3352.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|